#!/usr/bin/env bash
# ðŸ“ Exemplo 4: GeraÃ§Ã£o de Manuscritos
# Demonstra geraÃ§Ã£o automÃ¡tica de manuscritos cientÃ­ficos

set -euo pipefail

echo "ðŸ“ LogLine Discovery Lab - Manuscript Generation Demo"
echo "====================================================="
echo ""

# Cores para output
GREEN='\033[0;32m'
BLUE='\033[0;34m'
YELLOW='\033[1;33m'
NC='\033[0m' # No Color

# Verificar se director estÃ¡ buildado
if [ ! -f "./target/release/director" ]; then
    echo -e "${YELLOW}âš ï¸  Director nÃ£o encontrado. Buildando...${NC}"
    cargo build --release -p director
fi

echo -e "${BLUE}ðŸ“‹ Passo 1: PreparaÃ§Ã£o${NC}"
echo ""

# Verificar PostgreSQL
if ! pg_isready -q; then
    echo -e "${YELLOW}âš ï¸  PostgreSQL nÃ£o estÃ¡ rodando${NC}"
    echo "Execute: brew services start postgresql@15"
    exit 1
fi
echo -e "${GREEN}âœ… PostgreSQL: OK${NC}"

# Verificar Ollama
if ! ollama list | grep -q "mistral:instruct"; then
    echo -e "${YELLOW}âš ï¸  Modelo Ollama nÃ£o encontrado${NC}"
    echo "Execute: ollama pull mistral:instruct"
    exit 1
fi
echo -e "${GREEN}âœ… Ollama: OK${NC}"

# Criar diretÃ³rio para manuscritos
MANUSCRIPTS_DIR="./manuscripts"
mkdir -p "$MANUSCRIPTS_DIR"
echo -e "${GREEN}âœ… DiretÃ³rio manuscritos: $MANUSCRIPTS_DIR${NC}"

echo ""
echo -e "${BLUE}ðŸ“‹ Passo 2: Escolher tipo de manuscrito${NC}"
echo ""

echo "OpÃ§Ãµes disponÃ­veis:"
echo "   1. AnÃ¡lise de gp41 (proteÃ­na de fusÃ£o)"
echo "   2. AnÃ¡lise de gp120 (proteÃ­na de superfÃ­cie)"
echo "   3. ComparaÃ§Ã£o gp41 vs gp120"
echo "   4. RevisÃ£o completa HIV proteÃ­nas"
echo ""

# Para demo, vamos gerar para gp41
PROTEIN="gp41"
echo -e "Gerando manuscrito para: ${GREEN}$PROTEIN${NC}"
echo ""

echo -e "${BLUE}ðŸ“‹ Passo 3: Gerando manuscrito via Director${NC}"
echo ""

# Query para geraÃ§Ã£o de manuscrito
QUERY="Gerar manuscrito cientÃ­fico completo sobre a proteÃ­na $PROTEIN do HIV-1. Incluir: abstract, introduÃ§Ã£o, metodologia, resultados (com mÃ©tricas RMSD e energia), discussÃ£o e referÃªncias."

echo -e "Query: ${YELLOW}$QUERY${NC}"
echo ""

echo -e "${GREEN}ðŸ¤– Director processando...${NC}"
echo ""

# Criar arquivo temporÃ¡rio com a query
TEMP_QUERY=$(mktemp)
echo "$QUERY" > "$TEMP_QUERY"

# Executar director (modo demo - mostra o que aconteceria)
echo "Simulando geraÃ§Ã£o de manuscrito..."
sleep 2

# Criar manuscrito de exemplo
TIMESTAMP=$(date +%Y-%m-%d_%H-%M-%S)
MANUSCRIPT_FILE="$MANUSCRIPTS_DIR/${PROTEIN}_analysis_${TIMESTAMP}.md"

cat > "$MANUSCRIPT_FILE" << 'EOF'
# Structural Analysis of HIV-1 gp41 Fusion Protein: An AI-Driven Approach

**Autores**: LogLine Discovery Lab  
**Data**: Novembro 2025  
**Keywords**: HIV-1, gp41, protein folding, molecular dynamics, AI-driven discovery

---

## Abstract

The HIV-1 envelope glycoprotein gp41 plays a critical role in viral fusion with host cell membranes. Understanding its structural dynamics is essential for developing effective fusion inhibitors. In this study, we employed AI-driven molecular dynamics simulations to analyze gp41 stability and conformational changes. Our analysis reveals a stable structure with mean RMSD of 3.2 Ã… and favorable energetics (-135.4 kcal/mol), confirming the structural integrity under physiological conditions. These findings provide insights for rational design of gp41-targeting therapeutics.

---

## 1. Introduction

### 1.1 Background

Human Immunodeficiency Virus type 1 (HIV-1) remains a significant global health challenge, with over 38 million people living with HIV/AIDS worldwide. The viral envelope glycoproteins gp120 and gp41 are essential for viral entry into host cells through membrane fusion [1].

### 1.2 The gp41 Fusion Protein

The gp41 protein is a type I transmembrane glycoprotein responsible for mediating fusion between the viral envelope and the host cell membrane. Its structure comprises:

- **Fusion peptide** (FP): Inserts into target membrane
- **Heptad repeat regions** (HR1 and HR2): Form six-helix bundle
- **Transmembrane domain** (TMD): Anchors protein in viral membrane
- **Cytoplasmic tail** (CT): Interacts with viral matrix

### 1.3 Objectives

This study aims to:
1. Characterize structural stability of gp41 through molecular dynamics
2. Quantify conformational flexibility via RMSD analysis
3. Assess energetic favorability of structural states
4. Identify potential therapeutic intervention points

---

## 2. Methodology

### 2.1 System Setup

**Structure Source**: HIV-1 gp41 crystal structure (PDB: 1AIK)  
**Simulation Software**: LogLine Discovery Lab (Rust-based MD engine)  
**Force Field**: CHARMM36m  
**Water Model**: TIP3P  
**Simulation Time**: 10 nanoseconds  
**Temperature**: 310 K (physiological)  
**Pressure**: 1 atm

### 2.2 Analysis Pipeline

The LogLine Discovery Lab employs an AI-driven pipeline:

1. **Structure Preparation**: Automated protonation and solvation
2. **Energy Minimization**: Steepest descent algorithm
3. **Equilibration**: NVT (100 ps) â†’ NPT (100 ps)
4. **Production MD**: 10 ns with 2 fs timestep
5. **AI Classification**: LLM-based query interpretation
6. **Automated Analysis**: RMSD, energy, stability flags

### 2.3 Metrics

- **RMSD** (Root Mean Square Deviation): Structural deviation from initial state
  - Threshold: 5.0 Ã… (instability flag if exceeded)
- **Energy**: Molecular potential energy
  - Threshold: -120 kcal/mol (favorable if below)
- **Stability Flag**: Automated detection of structural anomalies

---

## 3. Results

### 3.1 Structural Stability

**Mean RMSD**: 3.2 Â± 0.4 Ã…  
**Status**: âœ… Stable (below 5.0 Ã… threshold)

The gp41 structure maintained high stability throughout the simulation, with RMSD consistently below the instability threshold. Minor fluctuations observed in loop regions are consistent with expected conformational flexibility.

### 3.2 Energetics

**Mean Energy**: -135.4 Â± 12.3 kcal/mol  
**Status**: âœ… Favorable (below -120 kcal/mol threshold)

Molecular potential energy remained stable and favorable, indicating a thermodynamically stable conformation. No significant energy barriers were observed during the simulation.

### 3.3 Conformational Analysis

Key observations:
- **HR1-HR2 Bundle**: Maintained stable six-helix bundle conformation
- **Fusion Peptide**: Minimal deviation from initial orientation
- **TMD Region**: High stability, essential for membrane anchoring
- **Loop Regions**: Expected flexibility (RMSF: 1.5-2.5 Ã…)

### 3.4 Instability Flags

**Status**: âœ… No instabilities detected

Automated AI analysis did not detect any structural instabilities, suggesting robust conformational integrity.

---

## 4. Discussion

### 4.1 Structural Implications

The observed stability of gp41 (RMSD 3.2 Ã…) is consistent with its functional role as a fusion machinery component. The six-helix bundle remains intact, confirming its critical role in bringing viral and cellular membranes into proximity [2].

### 4.2 Therapeutic Targeting

The stability of the HR1-HR2 interface suggests potential for peptide-based fusion inhibitors (e.g., enfuvirtide/T-20). Our analysis identifies conserved regions suitable for:
- Small molecule inhibitors
- Antibody targeting (broadly neutralizing antibodies)
- Peptide mimetics

### 4.3 Comparison with Literature

Our findings align with previous crystallographic and MD studies [3,4]:
- Similar RMSD values (3-4 Ã…)
- Consistent energetic profiles
- Stable six-helix bundle formation

### 4.4 AI-Driven Advantages

The LogLine Discovery Lab platform offers:
- **Speed**: 10x faster than traditional pipelines
- **Automation**: End-to-end from query to manuscript
- **Reproducibility**: Fully documented computational workflow
- **Accessibility**: Natural language interface for non-experts

---

## 5. Conclusions

This AI-driven structural analysis of HIV-1 gp41 reveals:

1. **High structural stability** (RMSD 3.2 Ã…)
2. **Favorable energetics** (-135.4 kcal/mol)
3. **Intact fusion machinery** (six-helix bundle)
4. **Therapeutic targeting opportunities** (HR1-HR2 interface)

These findings validate the LogLine Discovery Lab approach for rapid, accurate protein structure analysis and provide a foundation for rational drug design targeting HIV-1 fusion.

---

## 6. Future Directions

- **Ligand Docking**: Screen potential fusion inhibitors
- **Mutation Analysis**: Study drug-resistant variants
- **Comparative Studies**: gp41 vs other viral fusion proteins
- **Machine Learning**: Predict optimal inhibitor binding sites

---

## References

[1] Harrison SC. (2008) Viral membrane fusion. *Nature Structural & Molecular Biology*, 15(7):690-698.

[2] Chan DC, Kim PS. (1998) HIV entry and its inhibition. *Cell*, 93(5):681-684.

[3] Caffrey M, et al. (1998) Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. *EMBO Journal*, 17(16):4572-4584.

[4] Weissenhorn W, et al. (1997) Atomic structure of the ectodomain from HIV-1 gp41. *Nature*, 387(6631):426-430.

[5] Eckert DM, Kim PS. (2001) Mechanisms of viral membrane fusion and its inhibition. *Annual Review of Biochemistry*, 70:777-810.

---

## Acknowledgments

Generated automatically by LogLine Discovery Lab AI system.  
For questions or collaborations: [contact information]

---

## Supplementary Materials

- **Simulation Parameters**: Available in `supplementary/sim_params.json`
- **Trajectory Files**: Available in `supplementary/trajectory.xtc`
- **Analysis Scripts**: Open source at github.com/danvoulez/lablab

---

*Document generated: Novembro 2025*  
*Version: 1.0*  
*LogLine Discovery Lab*
EOF

# Cleanup
rm -f "$TEMP_QUERY"

echo -e "${GREEN}âœ… Manuscrito gerado com sucesso!${NC}"
echo ""

echo -e "${BLUE}ðŸ“‹ Passo 4: Visualizar manuscrito${NC}"
echo ""

echo "LocalizaÃ§Ã£o: ${GREEN}$MANUSCRIPT_FILE${NC}"
echo ""
echo "Estrutura do manuscrito:"
echo "   ðŸ“„ Abstract (250 palavras)"
echo "   ðŸ“– 1. Introduction (contexto + objetivos)"
echo "   ðŸ”¬ 2. Methodology (setup + pipeline)"
echo "   ðŸ“Š 3. Results (mÃ©tricas + anÃ¡lises)"
echo "   ðŸ’¡ 4. Discussion (interpretaÃ§Ã£o + implicaÃ§Ãµes)"
echo "   âœ… 5. Conclusions (sumÃ¡rio de findings)"
echo "   ðŸ“š 6. References (citaÃ§Ãµes automÃ¡ticas)"
echo ""

# Contar palavras
WORD_COUNT=$(wc -w < "$MANUSCRIPT_FILE")
echo "Total de palavras: ${YELLOW}$WORD_COUNT${NC}"
echo ""

echo -e "${BLUE}ðŸ“‹ Passo 5: PrÃ³ximos passos${NC}"
echo ""

echo "Com o manuscrito gerado, vocÃª pode:"
echo ""
echo "1. ${GREEN}Revisar e editar${NC}"
echo "   â†’ Ajustar detalhes cientÃ­ficos especÃ­ficos"
echo "   â†’ Adicionar dados experimentais complementares"
echo "   â†’ Refinar linguagem acadÃªmica"
echo ""
echo "2. ${GREEN}Adicionar figuras${NC}"
echo "   â†’ GrÃ¡ficos de RMSD e energia"
echo "   â†’ Estruturas 3D (PyMOL, VMD)"
echo "   â†’ Diagramas de mecanismos"
echo ""
echo "3. ${GREEN}Validar com colaboradores${NC}"
echo "   â†’ Enviar para co-autores"
echo "   â†’ Revisar metodologia"
echo "   â†’ Confirmar resultados"
echo ""
echo "4. ${GREEN}Submeter para peer review${NC}"
echo "   â†’ Formatar conforme journal guidelines"
echo "   â†’ Preparar supplementary materials"
echo "   â†’ Submeter via editorial system"
echo ""

echo -e "${BLUE}ðŸ“š Recursos Ãšteis${NC}"
echo ""
echo "â€¢ Template LaTeX: templates/manuscript_latex.tex"
echo "â€¢ FormataÃ§Ã£o JACS: templates/jacs_format.md"
echo "â€¢ FormataÃ§Ã£o Nature: templates/nature_format.md"
echo "â€¢ Checklist submissÃ£o: docs/submission_checklist.md"
echo ""

# Abrir manuscrito automaticamente (macOS)
if [[ "$OSTYPE" == "darwin"* ]]; then
    echo "Abrindo manuscrito..."
    open "$MANUSCRIPT_FILE"
elif [[ "$OSTYPE" == "linux-gnu"* ]]; then
    if command -v xdg-open &> /dev/null; then
        xdg-open "$MANUSCRIPT_FILE"
    fi
fi

echo ""
echo -e "${GREEN}ðŸŽ‰ Demo completo!${NC}"
echo ""
echo "Manuscrito salvo em: $MANUSCRIPT_FILE"
